Companies researching CAR-T Cell Therapy

CAR‑T cell therapy engineers a patient's T cells to express chimeric antigen receptors, enabling them to identify and eliminate cancer cells, and is often classified as a cell‑based gene therapy.

List of companies that research CAR-T Cell Therapy

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Hospitals and Health Care

138k

$94B

CAR-T Cell Therapy

Country flag

United States

Higher Education

18k

$5.1B

CAR-T Cell Therapy

Country flag

United States

Pharmaceutical Manufacturing

39k

$46B

CAR-T Cell Therapy

Country flag

United States

Hospitals and Health Care

21k

$3.8B

CAR-T Cell Therapy

Country flag

United States

Biotechnology Research

2.4k

$90M

CAR-T Cell Therapy

Country flag

United States

Biotechnology Research

4k

$45M

CAR-T Cell Therapy

Country flag

United States

Hospitals and Health Care

12k

$2.4B

CAR-T Cell Therapy

Country flag

United States

Biotechnology Research

15k

$27B

CAR-T Cell Therapy

Country flag

United States

Hospitals and Health Care

3.9k

$500M

CAR-T Cell Therapy

Country flag

United States

Hospitals and Health Care

8k

$1.9B

CAR-T Cell Therapy

Showing top companies out of 470 that research CAR-T Cell Therapy. Get the full list on TheirStack.

Frequently asked questions